TYRO3 and neoplasm: Of note, the expression of TYRO3, AXL, and MERTK, as well as their ligands, can be dramatically upregulated on immunosuppressive MDSCs in Braf-V600E/Pten deficient melanoma tumor-bearing C57BL/6 mice (175).